Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study - http://proactivecapital.com/2013...
CEL-SCI Corporation Announces That NIAID Collaborators Have Submitted Bird Flu Study for Publication to Prestigious Scientific Journal - http://proactivecapital.com/2013...
The Vatican’s Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Announce Highlights of the Upcoming Second International Adult Stem Cell Conference - http://proactivecapital.com/2013...
Unilife to Showcase Broad Portfolio of Innovative, Differentiated Injectable Drug Delivery Systems at Pharmapack Europe: Continued Expansion of Unilife’s World-Class Commercial Development Team - http://www.proactivenewsroom.com/2013...
TG Therapeutics, Inc. Opens Expansion Cohorts in Its Phase I/II Trial of TG-1101 (Ublituximab) in Patients With Rituximab Relapsed or Refractory B-cell Non-Hodgkin’s Lymphoma - http://www.proactivenewsroom.com/2013...
Ladenburg Thalmann & Co Report on IPCI: Rexista Abuse-Deterrent Oxycodone Data Offers Next Potential Catalyst; Introducing 2013 Quarterly Financial Forecast. Reiterate Buy Rating and $7.00 PT. - http://www.proactivenewsroom.com/2013...